Timetable: Initial (full) marketing authorisation application accelerated assessment timetables

Timetable: Initial (full) marketing authorisation application assessment

Timetable: Informed consent and multiple application

Timetable: Initial (full) marketing authorisation application assessment

Timetable: Initial (full) marketing authorisation application accelerated assessment timetables - Advanced therapy medicinal product (ATMP)

Timetable: Extension application

Timetable: Initial (full) marketing authorisation application accelerated assessment timetables

Timetable accelerated assessment request for initial marketing authorisation applications

Timetable: Extension application - ATMP

Human medicines European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Mylan, sitagliptin hydrochloride monohydrate,metformin hydrochloride, Date of authorisation: 16/02/2022, Revision: 3, Status: Authorised